Ambient fine particulate matter and cardiopulmonary health risks in China
Abstract. In China, the level of ambient fine particulate matter (PM2.5) pollution far exceeds the air quality standards recommended by the World Health Organization. Moreover, the health effects of PM2.5 exposure have become a major public health issue. More than half of PM2.5-related excess deaths...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2023-02-01
|
| Series: | Chinese Medical Journal |
| Online Access: | http://journals.lww.com/10.1097/CM9.0000000000002218 |
| _version_ | 1797840189913038848 |
|---|---|
| author | Tiantian Li Yi Zhang Ning Jiang Hang Du Chen Chen Jiaonan Wang Qiutong Li Da Feng Xiaoming Shi Jing Ni |
| author_facet | Tiantian Li Yi Zhang Ning Jiang Hang Du Chen Chen Jiaonan Wang Qiutong Li Da Feng Xiaoming Shi Jing Ni |
| author_sort | Tiantian Li |
| collection | DOAJ |
| description | Abstract. In China, the level of ambient fine particulate matter (PM2.5) pollution far exceeds the air quality standards recommended by the World Health Organization. Moreover, the health effects of PM2.5 exposure have become a major public health issue. More than half of PM2.5-related excess deaths are caused by cardiopulmonary disease, which has become a major health risk associated with PM2.5 pollution. In this review, we discussed the latest epidemiological advances relating to the health effects of PM2.5 on cardiopulmonary diseases in China, including studies relating to the effects of PM2.5 on mortality, morbidity, and risk factors for cardiovascular and respiratory diseases. These data provided important evidence to highlight the cardiopulmonary risk associated with PM2.5 across the world. In the future, further studies need to be carried out to investigate the specific relationship between the constituents and sources of PM2.5 and cardiopulmonary disease. These studies provided scientific evidence for precise reduction measurement of pollution sources and public health risks. It is also necessary to identify effective biomarkers and elucidate the biological mechanisms and pathways involved; this may help us to take steps to reduce PM2.5 pollution and reduce the incidence of cardiopulmonary disease. |
| first_indexed | 2024-04-09T16:10:47Z |
| format | Article |
| id | doaj.art-2009c42d1cf54506a0b89812de12970f |
| institution | Directory Open Access Journal |
| issn | 0366-6999 2542-5641 |
| language | English |
| last_indexed | 2024-04-09T16:10:47Z |
| publishDate | 2023-02-01 |
| publisher | Wolters Kluwer |
| record_format | Article |
| series | Chinese Medical Journal |
| spelling | doaj.art-2009c42d1cf54506a0b89812de12970f2023-04-24T10:06:47ZengWolters KluwerChinese Medical Journal0366-69992542-56412023-02-01136328729410.1097/CM9.0000000000002218202302050-00004Ambient fine particulate matter and cardiopulmonary health risks in ChinaTiantian Li0Yi Zhang1Ning Jiang2Hang Du3Chen Chen4Jiaonan Wang5Qiutong Li6Da Feng7Xiaoming Shi8Jing Ni9China CDC Key Laboratory of Environment and Population Health, National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing 100021, China.China CDC Key Laboratory of Environment and Population Health, National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing 100021, China.China CDC Key Laboratory of Environment and Population Health, National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing 100021, China.China CDC Key Laboratory of Environment and Population Health, National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing 100021, China.China CDC Key Laboratory of Environment and Population Health, National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing 100021, China.China CDC Key Laboratory of Environment and Population Health, National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing 100021, China.China CDC Key Laboratory of Environment and Population Health, National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing 100021, China.China CDC Key Laboratory of Environment and Population Health, National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing 100021, China.China CDC Key Laboratory of Environment and Population Health, National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing 100021, China.China CDC Key Laboratory of Environment and Population Health, National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing 100021, China.Abstract. In China, the level of ambient fine particulate matter (PM2.5) pollution far exceeds the air quality standards recommended by the World Health Organization. Moreover, the health effects of PM2.5 exposure have become a major public health issue. More than half of PM2.5-related excess deaths are caused by cardiopulmonary disease, which has become a major health risk associated with PM2.5 pollution. In this review, we discussed the latest epidemiological advances relating to the health effects of PM2.5 on cardiopulmonary diseases in China, including studies relating to the effects of PM2.5 on mortality, morbidity, and risk factors for cardiovascular and respiratory diseases. These data provided important evidence to highlight the cardiopulmonary risk associated with PM2.5 across the world. In the future, further studies need to be carried out to investigate the specific relationship between the constituents and sources of PM2.5 and cardiopulmonary disease. These studies provided scientific evidence for precise reduction measurement of pollution sources and public health risks. It is also necessary to identify effective biomarkers and elucidate the biological mechanisms and pathways involved; this may help us to take steps to reduce PM2.5 pollution and reduce the incidence of cardiopulmonary disease.http://journals.lww.com/10.1097/CM9.0000000000002218 |
| spellingShingle | Tiantian Li Yi Zhang Ning Jiang Hang Du Chen Chen Jiaonan Wang Qiutong Li Da Feng Xiaoming Shi Jing Ni Ambient fine particulate matter and cardiopulmonary health risks in China Chinese Medical Journal |
| title | Ambient fine particulate matter and cardiopulmonary health risks in China |
| title_full | Ambient fine particulate matter and cardiopulmonary health risks in China |
| title_fullStr | Ambient fine particulate matter and cardiopulmonary health risks in China |
| title_full_unstemmed | Ambient fine particulate matter and cardiopulmonary health risks in China |
| title_short | Ambient fine particulate matter and cardiopulmonary health risks in China |
| title_sort | ambient fine particulate matter and cardiopulmonary health risks in china |
| url | http://journals.lww.com/10.1097/CM9.0000000000002218 |
| work_keys_str_mv | AT tiantianli ambientfineparticulatematterandcardiopulmonaryhealthrisksinchina AT yizhang ambientfineparticulatematterandcardiopulmonaryhealthrisksinchina AT ningjiang ambientfineparticulatematterandcardiopulmonaryhealthrisksinchina AT hangdu ambientfineparticulatematterandcardiopulmonaryhealthrisksinchina AT chenchen ambientfineparticulatematterandcardiopulmonaryhealthrisksinchina AT jiaonanwang ambientfineparticulatematterandcardiopulmonaryhealthrisksinchina AT qiutongli ambientfineparticulatematterandcardiopulmonaryhealthrisksinchina AT dafeng ambientfineparticulatematterandcardiopulmonaryhealthrisksinchina AT xiaomingshi ambientfineparticulatematterandcardiopulmonaryhealthrisksinchina AT jingni ambientfineparticulatematterandcardiopulmonaryhealthrisksinchina |